Cargando…
Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism
AIMS/INTRODUCTION: In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated. MATERIAL AND METHODS: The German nationwide inpatient sample of the years 2005–2018 was analyzed. Hospitalized PE patients were stratified for diabete...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017616/ https://www.ncbi.nlm.nih.gov/pubmed/34779148 http://dx.doi.org/10.1111/jdi.13710 |
_version_ | 1784688815113240576 |
---|---|
author | Schmitt, Volker H Hobohm, Lukas Sivanathan, Visvakanth Brochhausen, Christoph Gori, Tommaso Münzel, Thomas Konstantinides, Stavros V Keller, Karsten |
author_facet | Schmitt, Volker H Hobohm, Lukas Sivanathan, Visvakanth Brochhausen, Christoph Gori, Tommaso Münzel, Thomas Konstantinides, Stavros V Keller, Karsten |
author_sort | Schmitt, Volker H |
collection | PubMed |
description | AIMS/INTRODUCTION: In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated. MATERIAL AND METHODS: The German nationwide inpatient sample of the years 2005–2018 was analyzed. Hospitalized PE patients were stratified for diabetes, and the impact of diabetes on in‐hospital events was investigated. RESULTS: Overall, 1,174,196 PE patients (53.8% aged ≥70 years, 53.5% women) and, among these, 219,550 (18.7%) diabetes patients were included. In‐hospital mortality rate amounted to 15.8%, and was higher in diabetes patients than in non‐diabetes patients (19.8% vs 14.8%, P < 0.001). PE patients with diabetes had a higher prevalence of cardiovascular risk factors, comorbidities, right ventricular dysfunction (31.8% vs 27.7%, P < 0.001), prolonged in‐hospital stay (11.0 vs 9.0 days, P < 0.001) and higher rates of adverse in‐hospital events. Remarkably, diabetes was independently associated with increased in‐hospital mortality (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.20–1.23, P < 0.001) when adjusted for age, sex and comorbidities. Within the observation period of 2005–2018, a relevant decrease of in‐hospital mortality in PE patients with diabetes was observed (25.5% to 16.8%). Systemic thrombolysis was more often administered to diabetes patients (OR 1.18, 95% CI 1.01–3.49, P < 0.001), and diabetes was associated with intracerebral (OR 1.19, 95% CI 1.12–1.26, P < 0.001), as well as gastrointestinal bleeding (OR 1.11, 95% CI 1.07–1.15, P < 0.001). Type 1 diabetes mellitus was shown to be a strong risk factor in PE patients for shock, right ventricular dysfunction, cardiopulmonary resuscitation and in‐hospital death (OR 1.75, 95% CI 1.61–1.90, P < 0.001). CONCLUSIONS: Despite the progress in diabetes treatments, diabetes is still associated with an unfavorable clinical patient profile and higher risk for adverse events, including substantially increased in‐hospital mortality in acute PE. |
format | Online Article Text |
id | pubmed-9017616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90176162022-04-21 Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism Schmitt, Volker H Hobohm, Lukas Sivanathan, Visvakanth Brochhausen, Christoph Gori, Tommaso Münzel, Thomas Konstantinides, Stavros V Keller, Karsten J Diabetes Investig Original Articles AIMS/INTRODUCTION: In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated. MATERIAL AND METHODS: The German nationwide inpatient sample of the years 2005–2018 was analyzed. Hospitalized PE patients were stratified for diabetes, and the impact of diabetes on in‐hospital events was investigated. RESULTS: Overall, 1,174,196 PE patients (53.8% aged ≥70 years, 53.5% women) and, among these, 219,550 (18.7%) diabetes patients were included. In‐hospital mortality rate amounted to 15.8%, and was higher in diabetes patients than in non‐diabetes patients (19.8% vs 14.8%, P < 0.001). PE patients with diabetes had a higher prevalence of cardiovascular risk factors, comorbidities, right ventricular dysfunction (31.8% vs 27.7%, P < 0.001), prolonged in‐hospital stay (11.0 vs 9.0 days, P < 0.001) and higher rates of adverse in‐hospital events. Remarkably, diabetes was independently associated with increased in‐hospital mortality (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.20–1.23, P < 0.001) when adjusted for age, sex and comorbidities. Within the observation period of 2005–2018, a relevant decrease of in‐hospital mortality in PE patients with diabetes was observed (25.5% to 16.8%). Systemic thrombolysis was more often administered to diabetes patients (OR 1.18, 95% CI 1.01–3.49, P < 0.001), and diabetes was associated with intracerebral (OR 1.19, 95% CI 1.12–1.26, P < 0.001), as well as gastrointestinal bleeding (OR 1.11, 95% CI 1.07–1.15, P < 0.001). Type 1 diabetes mellitus was shown to be a strong risk factor in PE patients for shock, right ventricular dysfunction, cardiopulmonary resuscitation and in‐hospital death (OR 1.75, 95% CI 1.61–1.90, P < 0.001). CONCLUSIONS: Despite the progress in diabetes treatments, diabetes is still associated with an unfavorable clinical patient profile and higher risk for adverse events, including substantially increased in‐hospital mortality in acute PE. John Wiley and Sons Inc. 2021-12-01 2022-04 /pmc/articles/PMC9017616/ /pubmed/34779148 http://dx.doi.org/10.1111/jdi.13710 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Schmitt, Volker H Hobohm, Lukas Sivanathan, Visvakanth Brochhausen, Christoph Gori, Tommaso Münzel, Thomas Konstantinides, Stavros V Keller, Karsten Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title | Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title_full | Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title_fullStr | Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title_full_unstemmed | Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title_short | Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
title_sort | diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017616/ https://www.ncbi.nlm.nih.gov/pubmed/34779148 http://dx.doi.org/10.1111/jdi.13710 |
work_keys_str_mv | AT schmittvolkerh diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT hobohmlukas diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT sivanathanvisvakanth diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT brochhausenchristoph diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT goritommaso diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT munzelthomas diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT konstantinidesstavrosv diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism AT kellerkarsten diabetesmellitusanditsimpactonmortalityrateandoutcomeinpulmonaryembolism |